Reliq Health Technologies Inc. (TSX-V: RHT.V) (OTCQB: RQHTF), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce that it has begun enrolling patients for the pilot of its remote patient monitoring and secure communication solution with The Feldman Institute in Baton Rouge, Louisiana. The pilot will evaluate the use of Reliq Health's technology with patients who have been discharged home after interventional pain management surgery, or have returned to their homes between treatments at The Feldman Institute. Read this full release and recent news releases for Reliq Health Technologies at http://marketnewsupdates.com/news/rqhtf.html
"We are very pleased to be enrolling patients and launching our pilot of the Reliq Health platform with The Feldman Institute," said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. "Our virtual care solution allows patients to receive high quality follow up care from the comfort of their own homes. Patients can communicate with their care team at The Feldman Institute using Reliq's cloud-based secure messaging, videoconferencing and virtual visits. The Reliq Health cloud provides access to patient education materials and instructional videos, empowering patients and their families to actively participate in their own care at home. We look forward to working with The Feldman Institute to improve treatment outcomes, reduce the risk of post-surgical complications and increase access to specialized pain management care for their chronic pain patients."
"One of our key goals at The Feldman Institute is to provide our patients with compassionate, accessible healthcare." said Dr. Arnold E. Feldman, Medical Director at The Feldman Institute and First Choice Surgery Center. "Our pilot with Reliq Health is designed to validate the use of their virtual care solution to help our patients better manage and document their symptoms in the home, and facilitate secure and timely communication between patients and family members and their care team at The Feldman Institute. Many of our patients travel great distances to receive cutting edge pain management surgery and other treatments at our facility. With Reliq Health's remote patient monitoring and secure communication platform we can continue to provide high quality care to these patients even after they return home."
The Feldman Institute's mission is to relieve chronic pain and restore health, comfort and quality of life in a collaborative and compassionate environment. The Feldman Institute is committed to eliminating pain through research and innovation while working closely with each patient to find their appropriate level of care. The Feldman Institute is dedicated to helping its patients through a comprehensive program of interventional pain management. The Feldman Institute specializes in performing minimally invasive, outpatient, and Endoscopic Discectomy procedures to address problems such as herniated discs, bulging discs, or ruptured discs. These advanced procedures are alternatives to open back and neck surgery and do not require general anesthesia. Patients undergoing these procedures experience far less trauma and a much shorter recovery time. The diagnosis and treatment techniques offered at the Feldman Institute represent the leading edge of recent medical advances.
In other healthcare & tech related developments and announcements in markets this week:
DealNet Capital Corp. (TSX-V: DLS.V) reported this week its results for the three and nine month periods ending September 30, 2016. All results are reported under International Financial Reporting Standards ("IFRS") and in Canadian dollars, unless otherwise specified. Read the full report at http://finance.yahoo.com/news/dealnet-reports-significant-cash-generation-123000830.html
CRH Medical Corporation (TSX: CRH.TO), a North American medical company that provides physicians with essential services and innovative products for the prevention and treatment of gastrointestinal diseases, also recently announced its unaudited interim financial results for the quarter ended September 30, 2016. "During the third quarter, we successfully completed the integration of the three acquisitions announced in June 2016. Our pipeline remains strong and we have taken meaningful steps to identify the human resources required to support operational and growth initiatives," said Edward Wright, Chief Executive Officer of CRH. "Our revenue growth and operating EBITDA margins continue to demonstrate the strength of our business strategy."
Patriot One Technologies Inc., (TSX-V: PAT.V ) OTCQB : PTOTF), developer of a revolutionary concealed weapons detection system, is pleased to announce that Company CEO Martin Cronin will be presenting at the 9th Annual LD Micro Main Event conference on December 7th at 8:00 AM (PT), Track 5. The event is located at the Luxe Sunset Boulevard Hotel, 11461 Sunset Blvd, Bel Air, CA.
Cannabix Technologies Inc. (CSE: BLO.CN) closed up slightly on Wednesday at $0.80 trading over 530,000 shares by the market close. Cannabix Technologies develops Cannabix Marijuana Breathalyzer for law enforcement and the work place in North America. The company’s Cannabix Marijuana Breathalyzer system is based on breath testing technology for recent use of the Tetrahydrocannabinol component of marijuana.
DISCLAIMER: MarketNewsUpdates.com (MNU) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. MNU is NOT affiliated in any manner with any company mentioned herein. MNU and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. MNU's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. MNU is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed MNU has been compensated three thousand nine hundred dollars for news coverage of the current press release issued by Reliq Health Technologies Inc. by a non-affiliated third party. MNU HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MNU undertakes no obligation to update such statements.
Media Contact email: firstname.lastname@example.org - +1(561)325-8757